Blog

What we ran, and what we found.

We put Kaimen Rigor to work on real evidence and report the results the way we ask others to: methods first, numbers in full, and the limits stated plainly. These are the studies behind the proof.

Retrospective studyAugust 2, 2026 11 min

Does sloppy early evidence predict a failed drug? A blinded, held-out retrospective

We built two independent cohorts of drug assets whose Phase 3 result is now known, scored each early publication blind to that result at full criterion granularity, and validated the candidates that survive against a held-out split.